CONSOLIDATED CONDENSED STATEMENTS OF CASH FLOWS (UNAUDITED) (in thousands) (USD $)	9 Months Ended
	Feb. 28, 2014	Feb. 28, 2013
Cash flows from operating activities:
Net income(loss)	$ (585)	$ 411
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization expense	170	161
Gain on sale of product line	(155)	0
Stock-based compensation	6	6
Non-cash interest expense	15	0
Change in fair value of warrant liability	(32)	0
Change in current assets and liabilities:
Accounts receivable	(243)	(420)
Prepaid expenses and other assets	179	(228)
Restricted cash	65	217
Accounts payable, accrued expenses and other liabilities	401	(187)
Deferred maintenance revenue	(135)	0
Net cash used in operating activities	(314)	(40)
Cash flows from investing activities:
Proceeds from sale of product line, net of direct cash expenses	2,432	0
Capital expenditures	(39)	(2)
Capitalized software development costs	(57)	(207)
Capitalized patent costs	(4)	(6)
Net cash provided by (used in) investing activities	2,332	(215)
Cash flows from financing activities:
Cost of treasury shares	(63)	0
Capitalized debt issuance costs	(32)	0
Proceeds from issuance of redeemable common stock, net of issuance costs	0	223
Repayment under debt agreements	(1,700)	(855)
Borrowing under debt agreements	0	300
Repayments under capital lease	(11)	(7)
Net cash used in financing activities	(1,825)	(339)
Effect of exchange rates on cash	(89)	1
Increase (decrease) in cash and cash equivalents	104	(593)
Cash and cash equivalents, beginning of period	1,188	595
Cash and cash equivalents, end of period	1,292	2
Supplemental disclosures of cash flow information:
Interest paid	205	110
Taxes paid	14	2
Noncash investing and financing activities:
Issuance of warrants	51	0
Purchase of property and equipment under capital lease	30	53
Accretion of redeemable common stock	$ 0	$ 112